Global Precision Medicine Competitive Landscape Professional Research Report 2025

Global Precision Medicine Competitive Landscape Professional Research Report 2025

Research Summary

Precision medicine, also known as personalized medicine, is an innovative approach to healthcare that takes into account individual differences in patients＇ genes, environments, and lifestyles. The aim of precision medicine is to tailor medical care and treatment plans to the specific characteristics of each patient, allowing for more accurate and effective interventions. Advances in genomics and molecular biology have played a crucial role in the development of precision medicine by providing insights into the genetic makeup of individuals and their susceptibility to certain diseases. This approach enables healthcare professionals to make data-driven decisions about prevention, diagnosis, and treatment, considering the unique genetic and molecular profiles of patients. Precision medicine holds the promise of improving patient outcomes, minimizing adverse effects, and optimizing the overall efficiency of healthcare by moving away from a one-size-fits-all model to a more individualized and targeted approach.

According to DIResearch's in-depth investigation and research, the global Precision Medicine market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.

The major global  manufacturers of Precision Medicine include Johnson & Johnson, Roche, Labcorp, Abbott Laboratories, Novartis, GE Healthcare, Illumina, Intel Corporation, bioMérieux, Cepheid, Qiagen, IBM, Thermo Fisher Scientific, Randox Laboratories, Almac Group, HealthCore Physicians Group etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Precision Medicine. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Precision Medicine market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Precision Medicine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Precision Medicine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Precision Medicine Include:

Johnson & Johnson

Roche

Labcorp

Abbott Laboratories

Novartis

GE Healthcare

Illumina

Intel Corporation

bioMérieux

Cepheid

Qiagen

IBM

Thermo Fisher Scientific

Randox Laboratories

Almac Group

HealthCore Physicians Group

Precision Medicine Product Segment Include:

Precision Diagnostics

Precision Therapies

Precision Medicine Product Application Include:

Oncology

Neurosciences

Immunology

Respiratory

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Precision Medicine Industry PESTEL Analysis

Chapter 3: Global Precision Medicine Industry Porter’s Five Forces Analysis

Chapter 4: Global Precision Medicine Major Regional Market Size and Forecast Analysis

Chapter 5: Global Precision Medicine Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Passenger Precision Medicine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Precision Medicine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Precision Medicine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Precision Medicine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Precision Medicine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Precision Medicine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Precision Medicine Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources